Our vision is to deliver a new brand of targeted medicines that will revolutionize healthcare

A new approach to fighting cancer and inflammatory disease

D5Pharma's next-generation screening technique allows us to identify DNA aptamers that have functional characteristics specific to critical therapeutic targets

Read more about the company's unique approach in these academic publications

Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers


Read More

Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival


Read More

Anti-TNFα aptamers


Read More

DNA aptamers in drug delivery


Read More